---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-326070"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2021-11-10T23:59:59+00:00"
generated_at: "2026-06-28T10:21:01.511315+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Teva issues €2.6B and $2B sustainability-linked notes; upsizes tender offer to $4B

## Summary
- €1.1B 3.750% notes due 2027 and €1.5B 4.375% notes due 2030 issued.
- $1B 4.750% notes due 2027 and $1B 5.125% notes due 2029 issued.
- Net proceeds used to fund tender offer for up to $4B (upsized from $3.5B) plus fees, debt repayment, and general purposes.
- Interest rates may increase by up to 0.375% from May 2026 if sustainability targets not met.
- Notes are senior unsecured obligations guaranteed by Teva; semi-annual interest begins May 9, 2022.

## SEC filing metadata
- accession: 0001193125-21-326070
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2021-11-10T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312521326070/0001193125-21-326070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312521326070/d249996d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-326070
- JSON: https://secwatch.observer/filing/0001193125-21-326070.json
- Plain text: https://secwatch.observer/filing/0001193125-21-326070.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.